Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

1.0K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.0K
Cranial Bones: Superior and Posterior View01:14

Cranial Bones: Superior and Posterior View

5.1K
The superior view of the cranium shows the frontal and paired parietal bones.
The frontal bone is the single bone that forms the forehead. At its anterior midline, between the eyebrows, there is a slight depression called the glabella. The frontal bone also forms the supraorbital margin of the orbit. Near the middle of this margin is the supraorbital foramen, the opening that provides passage for a sensory nerve to the forehead. The frontal bone is thickened just above each supraorbital margin,...
5.1K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

217
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
217
Anatomy of the Heart01:27

Anatomy of the Heart

119.8K
The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.8K
Anatomy of the Circulatory System02:03

Anatomy of the Circulatory System

98.1K
The human circulatory system consists of blood, blood vessels that carry blood away from the heart, around the body, and back to the heart, and the heart itself, which acts as a central pump. The systemic circuit supplies blood to the whole body, the coronary circuit supplies blood to the heart, and the pulmonary circuit supplies blood flow between the heart and lungs.
98.1K
Social Loafing01:37

Social Loafing

39.7K
Another way in which a group presence can affect performance is social loafing—the exertion of less effort by a person working together with a group. Social loafing occurs when our individual performance cannot be evaluated separately from the group. Thus, group performance declines on easy tasks (Karau & Williams, 1993). Essentially individual group members loaf and let other group members pick up the slack. Because each individual’s efforts cannot be evaluated,...
39.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "European experience on oncological outcomes of patients with early stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomy" [Lung Cancer J. 217 (2026) 109410].

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Corrigendum to "European experience on oncological outcomes of patients with early-stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomy" Published in [Lung Cancer https://doi.org/10.1016/j.lungcan.2026.109410].

Lung cancer (Amsterdam, Netherlands)·2026
Same author

European experience on oncological outcomes of patients with early-stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomy.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Role of Maximum Standardized Uptake Volume in Predicting Tumor Spread Through Air Spaces in Stage IA Lung Cancers Smaller than 2 cm.

Cancers·2026
Same author

European analysis of patients with early-stage lung adenocarcinoma and invasive pathologic features who underwent lobectomy versus segmentectomy.

The Journal of thoracic and cardiovascular surgery·2026
Same author

European prognosis evaluation of early-stage lung adenocarcinoma patterns after lobectomy versus segmentectomy based on clinical stage settings.

JTCVS open·2026

Related Experiment Video

Updated: Feb 4, 2026

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

1.1K

Superior Vena Cava Replacement for Thymic Malignancies.

Giulio Maurizi1, Camilla Poggi2, Antonio D'Andrilli1

  • 1Department of Thoracic Surgery, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.

The Annals of Thoracic Surgery
|October 15, 2018
PubMed
Summary
This summary is machine-generated.

Radical resection of advanced thymic tumors invading the superior vena cava (SVC) is feasible with prosthetic replacement. Pericardial conduits offer excellent long-term patency and survival outcomes for these challenging cases.

More Related Videos

Patch Angioplasty in the Rat Aorta or Inferior Vena Cava
06:04

Patch Angioplasty in the Rat Aorta or Inferior Vena Cava

Published on: February 27, 2017

11.0K
Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
05:37

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis

Published on: December 22, 2017

25.8K

Related Experiment Videos

Last Updated: Feb 4, 2026

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

1.1K
Patch Angioplasty in the Rat Aorta or Inferior Vena Cava
06:04

Patch Angioplasty in the Rat Aorta or Inferior Vena Cava

Published on: February 27, 2017

11.0K
Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
05:37

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis

Published on: December 22, 2017

25.8K

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Oncology
  • Surgical Oncology

Background:

  • Advanced thymic tumors can invade the superior vena cava (SVC).
  • Radical resection is achievable with SVC prosthetic replacement in select cases.
  • Multimodality therapy is crucial for managing these complex malignancies.

Purpose of the Study:

  • To evaluate the safety and efficacy of SVC resection and prosthetic reconstruction for advanced thymic malignancies.
  • To assess oncologic outcomes, including survival and recurrence rates.
  • To compare different prosthetic conduit materials.

Main Methods:

  • Retrospective analysis of 27 patients with thymic tumors invading the SVC.
  • Surgical resection with SVC prosthetic replacement using various conduits (bovine/porcine pericardium, polytetrafluoroethylene, saphenous vein).
  • Assessment of perioperative complications, survival, and recurrence rates.

Main Results:

  • Complete (R0) resections were achieved in all patients.
  • The overall mortality rate was 7.4%, with no deaths related to vascular reconstruction.
  • Five-year cancer-specific survival was 75.4%, with thymoma patients showing 93.8% survival.
  • Thymic carcinoma histology was a negative prognostic factor.
  • Pericardial conduits demonstrated 100% long-term patency.

Conclusions:

  • En bloc resection and SVC conduit reconstruction enable radical treatment of locally advanced thymic tumors.
  • Heterologous pericardial conduits are a preferred option due to excellent long-term patency.
  • This approach offers a viable solution for managing challenging SVC-infiltrating thymic malignancies.